TLR4 regulates RORγt+ regulatory T-cell responses and susceptibility to colon inflammation through interaction with Akkermansia muciniphila

被引:105
|
作者
Liu, Yaojiang [1 ,2 ]
Yang, Min [1 ]
Tang, Li [1 ]
Wang, Fengchao [3 ]
Huang, Shengjie [2 ]
Liu, Shuang [1 ]
Lei, Yuanyuan [1 ]
Wang, Sumin [1 ]
Xie, Zhuo [1 ]
Wang, Wei [1 ]
Zhao, Xiaoyan [1 ]
Tang, Bo [1 ]
Yang, Shiming [1 ]
机构
[1] Third Mil Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Chongqing 400037, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Chongqing 400010, Peoples R China
[3] Third Mil Med Univ, Coll Prevent Med, Inst Combined Injury, State Key Lab Trauma Burns & Combined Injury, Chongqing 400037, Peoples R China
基金
中国国家自然科学基金;
关键词
TOLL-LIKE RECEPTORS; GUT MICROBIOTA; BOWEL-DISEASE; IMMUNE-RESPONSES; COLITIS; PATHOGENESIS; COMMENSAL; MICE; COLONIZATION; POPULATION;
D O I
10.1186/s40168-022-01296-x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Well-balanced interactions between gut microbiota and the immune system are essential to prevent chronic intestinal inflammation, as observed in inflammatory bowel diseases (IBD). Toll-like receptor 4 (TLR4) functions as a sensor mediating the crosstalk between the intestinal commensal microbiome and host immunity, but the influence of TLR4 on the shaping of intestinal microbiota and immune responses during colon inflammation remains poorly characterized. We investigated whether the different susceptibilities to colitis between wild-type (WT) and TLR4(-/-) mice were gut microbiota-dependent and aimed to identify the potential immunity modulation mechanism. Methods: We performed antibiotic depletion of the microbiota, cohousing experiments, and faecal microbiota transplantation (FMT) in WT and TLR4(-/-) mice to assess the influence of TLR4 on intestinal microbial ecology. 16S rRNA sequencing was performed to dissect microbial discrepancies, and dysbiosis-associated immune perturbation was investigated by flow cytometry. Akkermansia muciniphila (A. muciniphila)-mediated immune modulation was confirmed through the T-cell transfer colitis model and bone marrow chimaera construction. Results: TLR4(-/-) mice experienced enhanced susceptibility to DSS-induced colitis. 16S rRNA sequencing showed notable discrepancy in the gut microbiota between WT and TLR4(-/-) mice. In particular, A. muciniphila contributed most to distinguishing the two groups. The T-cell transfer colitis model and bone marrow transplantation (BMT) consistently demonstrated that A. muciniphila ameliorated colitis by upregulating ROR gamma t(+) Treg cell-mediated immune responses. Mucosal biopsies from human manifested parallel outcomes with colon tissue from WT mice, as evidenced by the positive correlation between TLR4 expression and intestinal A. muciniphila colonization during homeostasis. Conclusions: Our results demonstrate a novel protective role of TLR4 against intestinal inflammation, wherein it can modulate A. muciniphila-associated immune responses. These findings provide a new perspective on host-commensal symbiosis, which may be beneficial for developing potential therapeutic strategies. [GRAPHICS] .
引用
收藏
页数:20
相关论文
共 50 条
  • [21] CD4+Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation
    Yurchenko, Ekaterina
    Levings, Megan K.
    Piccirillo, Ciriaco A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (12) : 3455 - 3466
  • [22] Inhibition of grass allergen-specific T-cell responses by CD4+CD25+CD127lo regulatory T-cell
    Wurtzen, P.
    Aasbjerg, K.
    Grauert, G.
    Koed, G.
    Backer, V
    Lund, K.
    ALLERGY, 2011, 66 : 513 - 513
  • [23] Regulatory T Cells from Colon Cancer Patients Inhibit Effector T-cell Migration through an Adenosine-Dependent Mechanism
    Sundstrom, Patrik
    Stenstad, Hanna
    Langenes, Veronica
    Ahlmanner, Filip
    Theander, Lisa
    Ndah, Tapuka Gordon
    Fredin, Kamilla
    Borjesson, Lars
    Gustavsson, Bengt
    Bastid, Jeremy
    Quiding-Jarbrink, Marianne
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (03) : 183 - 193
  • [24] GABA regulates the proliferation and apoptosis of MAC-T cells through the LPS-induced TLR4 signaling pathway
    Wang, Yue-Ying
    Sun, Shi-Ping
    Zhu, He-Shui
    Jiao, Xian-Qin
    Zhong, Kai
    Guo, Yu-Jie
    Zha, Guang-Ming
    Han, Li-Qiang
    Yang, Guo-Yu
    Li, He-Ping
    RESEARCH IN VETERINARY SCIENCE, 2018, 118 : 395 - 402
  • [25] Ulinastatin mediates suppression of regulatory T cells through TLR4/NF-κB signaling pathway in murine sepsis
    Cao, Chao
    Yin, Chengfen
    Chai, Yanfen
    Jin, Heng
    Wang, Lijun
    Shou, Songtao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 64 : 411 - 423
  • [26] Regulatory T-cell expression of CCR4 is required to prevent cutaneous and pulmonary inflammation.
    Sather, Blythe D.
    Gyarmati, Dora
    Miazgowicz, Mike
    Fontenot, Jason D.
    Rudensky, Alexander Y.
    Campbell, Daniel J.
    CLINICAL IMMUNOLOGY, 2006, 119 : S206 - S206
  • [27] Induction of T cell-independent hypermutated and protective IgG and IgA antibody responses by engagement of TLR4 or TLR5 and BCR
    Rivera, Carlos Eduardo
    Chupp, Daniel P.
    Yan, Hui
    Im, John
    Fernandez, Maria
    Zan, Hong
    Xu, Zhenming
    Casali, Paolo
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [28] Pyroptotic macrophages promote proliferation and chemotherapy resistance of peripheral T-cell lymphoma via TLR4 signaling pathway
    Zhang, Han
    Li, Liru
    Zhang, Zijian
    Gao, Shiqi
    Yang, Mingzhe
    Ma, Wenjie
    Li, Hongbin
    Zhao, Wenhui
    Yang, Huike
    Zhang, Yue
    Zhao, Shu
    CANCER SCIENCE, 2024, 115 (07) : 2444 - 2460
  • [29] Signaling through CD43 regulates CD4 T-cell trafficking
    Mody, Purvi D.
    Cannon, Judy L.
    Bandukwala, Hozefa S.
    Blaine, Kelly M.
    Schilling, Alexander B.
    Swier, Kevin
    Sperling, Anne I.
    BLOOD, 2007, 110 (08) : 2974 - 2982
  • [30] MC1R regulates T regulatory cell differentiation through metabolic reprogramming to promote colon cancer
    Zhu, Shaoliang
    Zou, Mengjie
    Li, Chunxing
    Tang, Yuntian
    Luo, Honglin
    Dong, Xiaofeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 138